Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Confronting Patients About Insufficient Effort: The Impact on Subsequent Symptom Validity and Memory Performance.
Tocopherol Derivative TFA-12 Promotes Myelin Repair in Experimental Models of Multiple Sclerosis.
Currently Approved And Emerging Oral Therapies In Multiple Sclerosis: An Update For The Ophthalmologist.
Bimonthly Evolution of Cortical Atrophy in Early Relapsing-Remitting Multiple Sclerosis over 2 Years: A Longitudinal Study.
Oral treatment with the herbal formula B401 protects against aging-dependent neurodegeneration by attenuating oxidative stress and apoptosis in the brain of R6/2 mice.
Switching and escalating therapy in long-lasting multiple sclerosis: not always necessary.
Can the Fatigue Severity Scale 7-item version be used across different patient populations as a generic fatigue measure - a comparative study using a Rasch model approach.
Mental comorbidity and multiple sclerosis: validating administrative data to support population-based surveillance.
NMDA receptor antibodies associated with distinct white matter syndromes.
Multiple sclerosis-like lesions and type I interferon signature in a patient with RVCL.
IL-6 and IL-17 synergistically promote viral persistence by inhibiting cellular apoptosis and cytotoxic T cell function.
Intestinal Microbiota as Modulators of the Immune System and Neuroimmune System: Impact on the Host Health and Homeostasis.
Modulating neurotoxicity through CX3CL1/CX3CR1 signaling.
Cerebrospinal fluid concentrations of ghrelin in patients with multiple sclerosis.
Are human endogenous retroviruses triggers of autoimmune diseases? Unveiling associations of three diseases and viral loci.
The relationship of age, function, and psychological distress in multiple sclerosis.
Association between IRF5 polymorphisms and autoimmune diseases: a meta-analysis.
Differential roles of resident microglia and infiltrating monocytes in murine CNS autoimmunity.
TREM2 regulates microglial cell activation in response to demyelination in vivo.
Antagonistic effects of IL-17 and D-resolvins on endothelial Del-1 expression through a GSK-3β-C/EBPβ pathway.
Erratum to: Altered serotonin transporter availability in patients with multiple sclerosis.
Interferon-beta affects mitochondrial activity in CD4+ lymphocytes: Implications for mechanism of action in multiple sclerosis.
Cerebral hypoperfusion in multiple sclerosis is reversible and mediated by endothelin-1.
Transient Brain Lesions in Neuro-Behçet's Disease without Systemic Involvement.
Smoking increases the risk of multiple sclerosis in Queensland, Australia.

Pages